Details

Last Funding Type

Series A

Last Funding Money Raised

$49M

Industries

Biopharma,Biotechnology,Health Care,Medical Device

Founded date

Jan 1, 2015

Number Of Employee

1 - 10

Operating Status

Active

Our expertise is drug development. Whether we are developing a reformulated product, a new chemical entity, or a biologic, the team at Arrivo BioVentures has expertise in identifying regulatory strategies to expedite the path to approval and the efficient implementation of the clinical programs themselves. We coordinate with the FDA (and other regulatory bodies) early and often to gain agreement on the development programs for our products, minimizing surprises and speeding implementation.